UBS Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.4M | Sell |
5,157,388
-1,896,283
| -27% | -$31.8M | 0.02% | 868 |
|
|
2025
Q1 | $108M | Buy |
7,053,671
+4,520,948
| +179% | +$69.5M | 0.02% | 697 |
|
|
2024
Q4 | $55.8M | Buy |
2,532,723
+889,529
| +54% | +$19.6M | 0.01% | 1049 |
|
|
2024
Q3 | $29.6M | Sell |
1,643,194
-369,941
| -18% | -$6.67M | 0.01% | 1070 |
|
|
2024
Q2 | $32.7M | Sell |
2,013,135
-185,067
| -8% | -$3.01M | 0.01% | 966 |
|
|
2024
Q1 | $31M | Buy |
2,198,202
+1,295,758
| +144% | +$18.3M | 0.01% | 979 |
|
|
2023
Q4 | $9.42M | Sell |
902,444
-429,968
| -32% | -$4.49M | ﹤0.01% | 1504 |
|
|
2023
Q3 | $13.6M | Buy |
1,332,412
+323,262
| +32% | +$3.3M | ﹤0.01% | 1235 |
|
|
2023
Q2 | $7.6M | Sell |
1,009,150
-42,102
| -4% | -$317K | ﹤0.01% | 1588 |
|
|
2023
Q1 | $9.3M | Sell |
1,051,252
-259,662
| -20% | -$2.3M | ﹤0.01% | 1401 |
|
|
2022
Q4 | $12M | Sell |
1,310,914
-51,277
| -4% | -$468K | ﹤0.01% | 1282 |
|
|
2022
Q3 | $11M | Sell |
1,362,191
-116,177
| -8% | -$937K | ﹤0.01% | 1227 |
|
|
2022
Q2 | $11.1M | Sell |
1,478,368
-450,356
| -23% | -$3.39M | ﹤0.01% | 1282 |
|
|
2022
Q1 | $18.1M | Sell |
1,928,724
-912,874
| -32% | -$8.57M | 0.01% | 1112 |
|
|
2021
Q4 | $22.8M | Buy |
2,841,598
+1,245,502
| +78% | +$9.98M | 0.01% | 1056 |
|
|
2021
Q3 | $15.5M | Buy |
1,596,096
+265,204
| +20% | +$2.58M | ﹤0.01% | 1262 |
|
|
2021
Q2 | $13.2M | Sell |
1,330,892
-131,023
| -9% | -$1.3M | ﹤0.01% | 1344 |
|
|
2021
Q1 | $16.9M | Sell |
1,461,915
-80,607
| -5% | -$930K | 0.01% | 1159 |
|
|
2020
Q4 | $14.9M | Buy |
1,542,522
+281,137
| +22% | +$2.71M | 0.01% | 1165 |
|
|
2020
Q3 | $11.4M | Sell |
1,261,385
-366,927
| -23% | -$3.31M | ﹤0.01% | 1218 |
|
|
2020
Q2 | $20.1M | Sell |
1,628,312
-156,920
| -9% | -$1.93M | 0.01% | 852 |
|
|
2020
Q1 | $16M | Sell |
1,785,232
-64,390
| -3% | -$578K | 0.01% | 862 |
|
|
2019
Q4 | $18.1M | Sell |
1,849,622
-459,106
| -20% | -$4.5M | 0.01% | 1121 |
|
|
2019
Q3 | $15.9M | Buy |
2,308,728
+790,970
| +52% | +$5.44M | 0.01% | 1112 |
|
|
2019
Q2 | $14M | Sell |
1,517,758
-116,218
| -7% | -$1.07M | 0.01% | 1183 |
|
|
2019
Q1 | $25.6M | Sell |
1,633,976
-114,506
| -7% | -$1.8M | 0.01% | 804 |
|
|
2018
Q4 | $27M | Sell |
1,748,482
-443,330
| -20% | -$6.84M | 0.01% | 684 |
|
|
2018
Q3 | $47.2M | Sell |
2,191,812
-252,498
| -10% | -$5.44M | 0.02% | 558 |
|
|
2018
Q2 | $59.4M | Buy |
2,444,310
+848,706
| +53% | +$20.6M | 0.03% | 450 |
|
|
2018
Q1 | $27.3M | Buy |
1,595,604
+305,767
| +24% | +$5.23M | 0.01% | 746 |
|
|
2017
Q4 | $24.4M | Sell |
1,289,837
-457,640
| -26% | -$8.67M | 0.01% | 808 |
|
|
2017
Q3 | $30.8M | Sell |
1,747,477
-264,977
| -13% | -$4.66M | 0.01% | 667 |
|
|
2017
Q2 | $66.9M | Buy |
2,012,454
+131,020
| +7% | +$4.35M | 0.03% | 371 |
|
|
2017
Q1 | $60.4M | Buy |
1,881,434
+366,743
| +24% | +$11.8M | 0.03% | 380 |
|
|
2016
Q4 | $54.9M | Sell |
1,514,691
-25,429
| -2% | -$922K | 0.03% | 387 |
|
|
2016
Q3 | $70.9M | Buy |
1,540,120
+537,057
| +54% | +$24.7M | 0.04% | 333 |
|
|
2016
Q2 | $50.4M | Sell |
1,003,063
-138,607
| -12% | -$6.96M | 0.03% | 395 |
|
|
2016
Q1 | $61.1M | Buy |
1,141,670
+3,542
| +0.3% | +$190K | 0.04% | 345 |
|
|
2015
Q4 | $74.7M | Buy |
1,138,128
+111,449
| +11% | +$7.32M | 0.05% | 316 |
|
|
2015
Q3 | $58M | Sell |
1,026,679
-345
| -0% | -$19.5K | 0.04% | 358 |
|
|
2015
Q2 | $60.7M | Sell |
1,027,024
-224,631
| -18% | -$13.3M | 0.04% | 376 |
|
|
2015
Q1 | $78M | Sell |
1,251,655
-17,201
| -1% | -$1.07M | 0.05% | 324 |
|
|
2014
Q4 | $73M | Buy |
+1,268,856
| New | +$73M | 0.05% | 324 |
|